THIOTEPA, BUSULFAN, AND CYCLOPHOSPHAMIDE - A NEW PREPARATIVE REGIMEN FOR AUTOLOGOUS MARROW OR BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MULTIPLE-MYELOMA

被引：1
|
作者：
DIMOPOULOS, MA [1 ]
ALEXANIAN, R [1 ]
PRZEPIORKA, D [1 ]
HESTER, J [1 ]
ANDERSSON, B [1 ]
GIRALT, S [1 ]
MEHRA, R [1 ]
VANBESIEN, K [1 ]
DELASALLE, KB [1 ]
READING, C [1 ]
DEISSEROTH, AB [1 ]
CHAMPLIN, RE [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT HEMATOL,BONE MARROW TRANSPLANTAT SECT,HOUSTON,TX 77030
来源：
BLOOD | 1993年 / 82卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2324 / 2328
页数：5
相关论文
共 50 条
  • [41] High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma
    谷景立
    China Medical Abstracts(Internal Medicine), 2019, 36 (04) : 230 - 231
  • [42] Autologous peripheral blood stem cell (PBSC) transplantation in multiple myeloma (MM); Results with busulfan (Bu) and cyclophosphamide (Cy) based conditioning regimen.
    Toor, AA
    Parthasarathy, M
    Cooney, J
    Creech, S
    Stiff, PJ
    BLOOD, 2001, 98 (11) : 685A - 686A
  • [43] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
    Song, Ga-Young
    Jung, Sung-Hoon
    Kim, Jin Seok
    Eom, Hyeon Seok
    Moon, Joon Ho
    Yhim, Ho-Young
    Kim, Kihyun
    Min, Chang-Ki
    Lee, Je-Jung
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] PROGNOSTIC FACTORS IN AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MULTIPLE-MYELOMA - AN EBMT REGISTRY STUDY
    BJORKSTRAND, B
    GOLDSTONE, AH
    LJUNGMAN, P
    BRANDT, L
    BRUNET, S
    CARLSON, K
    PRENTICE, HG
    CAVO, M
    SAMSON, D
    DELAURENZI, A
    VERDONCK, LF
    PROCTOR, S
    FERRANT, A
    SIERRA, J
    AUZANNEAU, G
    TROUSSARD, X
    GRAVETT, P
    REMES, K
    GAHRTON, G
    LEUKEMIA & LYMPHOMA, 1994, 15 (3-4) : 265 - 272
  • [45] AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN MULTIPLE-MYELOMA - A STUDY OF THE EUROPEAN BMT REGISTRY
    BJORKSTRAND, B
    LJUNGMAN, P
    BRANDT, L
    BRUNET, S
    CARLSON, K
    CAVO, M
    FASSAS, A
    FERRANT, A
    GOLDSTONE, AH
    DELAURENZI, A
    PRENTICE, HG
    REMES, K
    SAMSON, D
    VERDONCK, LF
    GAHRTON, G
    BLOOD, 1994, 84 (10) : A535 - A535
  • [46] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma
    Murakami, H
    Fujii, H
    Inaba, T
    Shimazaki, C
    Okamoto, S
    Miwa, A
    Sawamura, M
    Abe, M
    Chou, T
    Asaoku, H
    Kitahara, Y
    Hayashi, K
    Kosaka, M
    Togawa, A
    Takatsuki, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) : 169 - 173
  • [47] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Mihee
    Min, Chang-Ki
    Lee, Ji Yun
    Jo, Jae-Cheol
    Yoon, Sung-Soo
    Lim, Sung-Nam
    Do, Young Rok
    Kim, Kihyun
    Lee, Jae Hoon
    Yoo, Kwai Han
    Bae, Sung Hwa
    Yi, Jun Ho
    Jung, Jongheon
    Eom, Hyeon-Seok
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S115 - S115
  • [48] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
    Mihee Kim
    Je-Jung Lee
    Chang-Ki Min
    Ji Yun Lee
    Jae-Cheol Jo
    Sung-Soo Yoon
    Sung-Nam Lim
    Young Rok Do
    Kihyun Kim
    Jae Hoon Lee
    Kwai Han Yoo
    Sung Hwa Bae
    Jun Ho Yi
    Jongheon Jung
    Hyeon-Seok Eom
    Sung-Hoon Jung
    Annals of Hematology, 2023, 102 : 2233 - 2240
  • [49] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
    Kim, Mihee
    Lee, Je-Jung
    Min, Chang-Ki
    Lee, Ji Yun
    Jo, Jae-Cheol
    Yoon, Sung-Soo
    Lim, Sung-Nam
    Do, Young Rok
    Kim, Kihyun
    Lee, Jae Hoon
    Yoo, Kwai Han
    Bae, Sung Hwa
    Yi, Jun Ho
    Jung, Jongheon
    Eom, Hyeon-Seok
    Jung, Sung-Hoon
    ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2233 - 2240
  • [50] TREATMENT OF AGGRESSIVE MULTIPLE-MYELOMA BY HIGH-DOSE CHEMORADIOTHERAPY AND AUTOLOGOUS BLOOD STEM-CELL GRAFT
    FERMAND, JP
    LEVY, Y
    GEROTA, J
    COSSET, JM
    BENBUNAN, M
    CASTAIGNE, S
    SELIGMANN, M
    BROUET, JC
    BONE MARROW TRANSPLANTATION, 1988, 3 : 80 - 80
12345